These data suggest that myeloid cell-mediated release of CHI3L1 contributes to the development of inflammatory cell accumulation and activity in NASH by being involved in the production of pro-inflammatory mediators, neutrophil chemoattractants, and inflammasome-mediated activation of IL-1β and IL-18. Here, IL1B is linked to metabolic dysfunction-associated steatohepatitis.